1. Structure of the human myostatin precursor and determinants of growth factor latency.
- Author
-
Cotton TR, Fischer G, Wang X, McCoy JC, Czepnik M, Thompson TB, and Hyvönen M
- Subjects
- Cell Line, Crystallography, X-Ray, Enzyme Activation physiology, Follistatin pharmacology, HEK293 Cells, Humans, Myostatin antagonists & inhibitors, Polymorphism, Genetic, Protein Structure, Secondary, Proteolysis, Transforming Growth Factor beta metabolism, Muscle, Skeletal metabolism, Myostatin metabolism, Protein Precursors metabolism
- Abstract
Myostatin, a key regulator of muscle mass in vertebrates, is biosynthesised as a latent precursor in muscle and is activated by sequential proteolysis of the pro-domain. To investigate the molecular mechanism by which pro-myostatin remains latent, we have determined the structure of unprocessed pro-myostatin and analysed the properties of the protein in its different forms. Crystal structures and SAXS analyses show that pro-myostatin adopts an open, V-shaped structure with a domain-swapped arrangement. The pro-mature complex, after cleavage of the furin site, has significantly reduced activity compared with the mature growth factor and persists as a stable complex that is resistant to the natural antagonist follistatin. The latency appears to be conferred by a number of distinct features that collectively stabilise the interaction of the pro-domains with the mature growth factor, enabling a regulated stepwise activation process, distinct from the prototypical pro-TGF-β1. These results provide a basis for understanding the effect of missense mutations in pro-myostatin and pave the way for the design of novel myostatin inhibitors., (© 2018 The Authors.)
- Published
- 2018
- Full Text
- View/download PDF